Patents by Inventor ANNE-CLAIRE LE MEUR

ANNE-CLAIRE LE MEUR has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Triazine formulations with a second active ingredient and surfactant(s)
    Patent number: 11911391
    Abstract: The present invention is related to novel compositions comprising at least one active ingredient of the family of the triazines combined with another active ingredient and specific compounds that allow the reduction of foam formation. More particularly, the invention relates to compositions in the form of aqueous suspensions comprising a triazine, an iron complex, and one or more surfactant(s) having a particular HLB.
    Type: Grant
    Filed: October 6, 2021
    Date of Patent: February 27, 2024
    Assignee: CEVA SANTE ANIMALE
    Inventors: Anne-Claire Le Meur, Florence Guimberteau
  • Triazine formulations with a second active ingredient and surfactant(s)
    Patent number: 11903946
    Abstract: The present invention is related to novel compositions comprising at least one active ingredient of the family of the triazines combined with another active ingredient and specific compounds that allow the reduction of foam formation. More particularly, the invention relates to compositions in the form of aqueous suspensions comprising a triazine, an iron complex, and one or more surfactant(s) having a particular HLB.
    Type: Grant
    Filed: October 6, 2021
    Date of Patent: February 20, 2024
    Assignee: CEVA SANTE ANIMALE
    Inventors: Anne-Claire Le Meur, Florence Guimberteau
  • Triazine formulations with a second active ingredient and surfactant(s)
    Patent number: 11903947
    Abstract: The present invention is related to novel compositions comprising at least one active ingredient of the family of the triazines combined with another active ingredient and specific compounds that allow the reduction of foam formation. More particularly, the invention relates to compositions in the form of aqueous suspensions comprising a triazine, an iron complex, and one or more surfactant(s) having a particular HLB.
    Type: Grant
    Filed: May 13, 2022
    Date of Patent: February 20, 2024
    Assignee: CEVA SANTE ANIMALE
    Inventors: Anne-Claire Le Meur, Florence Guimberteau
  • TRIAZINE FORMULATIONS WITH A SECOND ACTIVE INGREDIENT AND SURFACTANT(S)
    Publication number: 20220265665
    Abstract: The present invention is related to novel compositions comprising at least one active ingredient of the family of the triazines combined with another active ingredient and specific compounds that allow the reduction of foam formation. More particularly, the invention relates to compositions in the form of aqueous suspensions comprising a triazine, an iron complex, and one or more surfactant(s) having a particular HLB.
    Type: Application
    Filed: May 13, 2022
    Publication date: August 25, 2022
    Inventors: ANNE-CLAIRE LE MEUR, FLORENCE GUIMBERTEAU
  • Triazine formulations with a second active ingredient and surfactant(s)
    Patent number: 11331321
    Abstract: The present invention is related to novel compositions comprising at least one active ingredient of the family of the triazines combined with another active ingredient and specific compounds that allow the reduction of foam formation. More particularly, the invention relates to compositions in the form of aqueous suspensions comprising a triazine, an iron complex, and one or more surfactant(s) having a particular HLB.
    Type: Grant
    Filed: December 6, 2013
    Date of Patent: May 17, 2022
    Assignee: CEVA SANTE ANIMALE
    Inventors: Anne-Claire Le Meur, Florence Guimberteau
  • TRIAZINE FORMULATIONS WITH A SECOND ACTIVE INGREDIENT AND SURFACTANT(S)
    Publication number: 20220023305
    Abstract: The present invention is related to novel compositions comprising at least one active ingredient of the family of the triazines combined with another active ingredient and specific compounds that allow the reduction of foam formation. More particularly, the invention relates to compositions in the form of aqueous suspensions comprising a triazine, an iron complex, and one or more surfactant(s) having a particular HLB.
    Type: Application
    Filed: October 6, 2021
    Publication date: January 27, 2022
    Inventors: ANNE-CLAIRE LE MEUR, FLORENCE GUIMBERTEAU
  • TRIAZINE FORMULATIONS WITH A SECOND ACTIVE INGREDIENT AND SURFACTANT(S)
    Publication number: 20220023304
    Abstract: The present invention is related to novel compositions comprising at least one active ingredient of the family of the triazines combined with another active ingredient and specific compounds that allow the reduction of foam formation. More particularly, the invention relates to compositions in the form of aqueous suspensions comprising a triazine, an iron complex, and one or more surfactant(s) having a particular HLB.
    Type: Application
    Filed: October 6, 2021
    Publication date: January 27, 2022
    Inventors: ANNE-CLAIRE LE MEUR, FLORENCE GUIMBERTEAU
  • Composition Containing a Somatostatin Analogue for Radiopharmaceutical Use
    Publication number: 20210128758
    Abstract: The present invention relates to a somatostatin analogue composition for radiopharmaceutical use, in particular for diagnostic or therapeutic use. More specifically the somatostatin analogue is a receptor-selective somatostatin peptide antagonist.
    Type: Application
    Filed: June 20, 2019
    Publication date: May 6, 2021
    Inventors: Romain Bejot, Bilal Karaaouil, Didier Kubiak, Anne-Claire Le Meur, Didier Nourrisson, Anne Petit, Joel Richard, Camille Toulisse
  • TRIAZINE FORMULATIONS WITH A SECOND ACTIVE INGREDIENT AND SURFACTANT(S)
    Publication number: 20150313940
    Abstract: The present invention is relative to novel compositions comprising at least one active ingredient of the family of the triazines combined with another active ingredient and specific compounds that allow the reduction of foam formation. More particularly, the invention relates to compositions in the form of aqueous suspensions comprising a triazine, an iron complex, and one or more surfactant(s) having a particular HLB.
    Type: Application
    Filed: December 6, 2013
    Publication date: November 5, 2015
    Inventors: ANNE-CLAIRE LE MEUR, FLORENCE GUIMBERTEAU